Answer
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead carries warnings about renal impairment, including acute renal failure and proximal renal tubulopathy reported with tenofovir alafenamide-containing products, and possible nephrotoxicity from chronic exposure to low tenofovir levels.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead 150mg/150mg/200mg/10mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 37Document updated
Sources checked